Park Ha Biological Technology is trading 8.33% higher at $2.86, with no clear catalyst identified.

  • No verified company announcement, filing, earnings release, or other clear September 24, 2026 catalyst was identified.
  • Recent coverage centers on securities-class-action reminders and a September 28 lead-plaintiff deadline; those reports do not establish a direct cause for today’s gain.